News
BioCer Present Newly EU Approved Super Rapid Plant-based Hemostat
BioCer Entwicklungs GmbH (BCE) a German implantable biological medical device development and manufacturing company announced today that it has achieved commercial approval to begin distribution in the EU, and international...[mehr]
BioCer Technology introduced to China
BioCer Introduce Latest Plant-based Hemostasis and Coated Hernia Repair Technologies to China[mehr]
BioCer Plant-based Hemostatic Innovation HaemoCer™ Receives CE Approval
BioCer Entwicklungs GmbH, a Bayreuth, Germany-based medical device manufacturer, are pleased to announce the CE approval of HaemoCer™, an Absorbable Polysaccharide Hemostat (APH).[mehr]
Die Klinikum Bayreuth GmbH kooperiert mit der BioCer Entwicklungs-GmbH
Die BioCer Entwicklungs-GmbH forscht seit 11 Jahren im Bereich der Medizinprodukte.[mehr]